Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for health advice, go to the NHS website. And if you are looking for the latest travel information, and advice about the government response to the outbreak, go to the gov.uk website.
NHS England is pleased to announce the appointment of a new National Clinical Director for Innovation, Professor Tony Young PhD, FRCS (Urol).
As National Clinical Director (NCD), Professor Young’s role will provide clinical leadership and support in delivering improved health outcomes across the five domains of the NHS Outcomes Framework. In particular Tony will focus on generating economic growth through innovation and driving the uptake of proven innovations across the healthcare system.
Professor Tony Young is a practicing Consultant Urological Surgeon at Southend University Hospital and Director of Medical Innovation at Anglia Ruskin University. He’s been instrumental in bringing together the partnership that forms the Anglia Ruskin MedTech Campus, which is set to become one of the world’s largest health innovation spaces. The project will bring £500m of inward investment into Essex, creating 12,000 new jobs and some 2 million sq ft of health innovation space across 3 sites in Harlow, Southend and Chelmsford.
Professor Young said: “It’s an honour to be appointed to this role. We’ve made great strides in transforming the medical innovation process during my time at Anglia Ruskin. I look forward to working with clinicians to help make innovation happen and bring the latest advances in technology and improvements in care pathways. The challenges we face as a national health system, particularly in the management of chronic disease are piled high. By encouraging economic growth and becoming early adopters of the latest innovations, we can rise to the challenge and help transform patient care and experience. ”
Dr Mike Bewick, Deputy Medical Director for NHS England, said: “We are facing a challenging but exciting time in delivering health services that meet the needs of both current and future healthcare consumers. Tony will be a great asset in helping move this agenda forward and we are looking forward to him joining the team.”
Professor Young will remain in his post at Anglia Ruskin during his time on secondment to NHS England and also continue as a frontline clinician at Southend University Hospital.